COLAIANNI, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 8.478
AS - Asia 3.569
EU - Europa 3.465
SA - Sud America 931
AF - Africa 262
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 16.726
Nazione #
US - Stati Uniti d'America 8.313
SG - Singapore 1.440
IT - Italia 1.435
CN - Cina 809
BR - Brasile 707
SE - Svezia 431
HK - Hong Kong 377
RU - Federazione Russa 352
DE - Germania 272
VN - Vietnam 267
FR - Francia 221
FI - Finlandia 206
GB - Regno Unito 159
CI - Costa d'Avorio 140
IN - India 132
UA - Ucraina 130
BD - Bangladesh 83
CA - Canada 80
AR - Argentina 69
ID - Indonesia 69
JP - Giappone 56
TR - Turchia 52
NL - Olanda 51
MX - Messico 50
CO - Colombia 44
IQ - Iraq 41
ES - Italia 38
PK - Pakistan 36
PL - Polonia 35
BE - Belgio 34
ZA - Sudafrica 32
MA - Marocco 28
EC - Ecuador 26
SA - Arabia Saudita 26
VE - Venezuela 26
AE - Emirati Arabi Uniti 20
IE - Irlanda 19
MY - Malesia 17
PE - Perù 17
PH - Filippine 17
PY - Paraguay 17
UZ - Uzbekistan 17
CL - Cile 15
AU - Australia 14
EG - Egitto 13
TH - Thailandia 13
AT - Austria 12
JM - Giamaica 12
IR - Iran 11
LB - Libano 11
TN - Tunisia 11
ET - Etiopia 10
KE - Kenya 10
OM - Oman 10
CZ - Repubblica Ceca 9
KR - Corea 9
LT - Lituania 9
AZ - Azerbaigian 8
JO - Giordania 8
IL - Israele 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PS - Palestinian Territory 6
SI - Slovenia 6
AL - Albania 5
DZ - Algeria 5
KG - Kirghizistan 5
AO - Angola 4
BY - Bielorussia 4
CY - Cipro 4
DK - Danimarca 4
HR - Croazia 4
PA - Panama 4
TW - Taiwan 4
CH - Svizzera 3
EU - Europa 3
GR - Grecia 3
NI - Nicaragua 3
NO - Norvegia 3
NP - Nepal 3
RS - Serbia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CR - Costa Rica 2
HN - Honduras 2
HU - Ungheria 2
LK - Sri Lanka 2
LV - Lettonia 2
MD - Moldavia 2
MN - Mongolia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
AM - Armenia 1
AQ - Antartide 1
BB - Barbados 1
BG - Bulgaria 1
Totale 16.709
Città #
Ashburn 908
Fairfield 806
Singapore 772
Woodbridge 568
San Jose 545
Chandler 447
Houston 436
Bari 387
Hong Kong 375
Cambridge 346
Nyköping 345
Seattle 345
Milan 320
Ann Arbor 305
Wilmington 279
Jacksonville 276
Beijing 249
Dallas 216
Abidjan 140
New York 126
Helsinki 121
Los Angeles 118
Rome 112
Lauterbourg 109
Roxbury 106
Nanjing 105
Lawrence 96
Munich 81
Ho Chi Minh City 79
Des Moines 74
Brooklyn 70
Santa Clara 70
Hanoi 68
Boardman 66
Grumo Appula 66
Inglewood 58
Council Bluffs 54
Jakarta 49
Columbus 48
São Paulo 47
Princeton 43
Chicago 42
Buffalo 41
San Diego 38
London 36
Tokyo 35
Brussels 34
Trani 33
Shenyang 30
Warsaw 30
Falkenstein 29
Frankfurt am Main 29
Montreal 29
Jiaxing 28
Rio de Janeiro 27
Dearborn 26
Mexico City 26
Orem 26
Dong Ket 25
Pune 25
Baghdad 24
Redwood City 24
Atlanta 23
Nanchang 23
Hebei 22
Paris 22
Turin 22
San Francisco 21
The Dalles 21
Moscow 20
Changsha 19
Dublin 18
Noicattaro 18
Tianjin 18
Toronto 18
Poplar 17
Falls Church 16
Manchester 16
Tashkent 16
Johannesburg 15
Phoenix 15
Turku 15
Ankara 14
Brasília 14
Chennai 14
Florence 14
Guangzhou 14
Nuremberg 14
Amsterdam 13
Figino 13
Shanghai 13
Zhengzhou 13
Boston 12
Campinas 12
Caracas 12
Charlotte 12
Dhaka 12
Lima 12
Mumbai 12
Denver 11
Totale 11.074
Nome #
Functions of vasopressin and oxytocin in bone mass regulation 467
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 286
The myokine irisin increases cortical bone mass 244
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 238
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 230
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 227
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 225
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 207
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 205
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 200
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 195
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 193
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 187
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 179
Irisin levels correlate with bone mineral density in soccer players 177
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 176
Mechanisms involved in childhood obesity-related bone fragility 176
Monoclonal antibodies for treating osteoporosis 174
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand Translocate in the Nucleus to Enhance Osteoblast Transcription 169
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 165
Sclerostin stimulates angiogenesis in human endothelial cells 165
Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes 164
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 162
Irisin and musculoskeletal health 161
Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells 160
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 157
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 154
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 153
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 148
The effects of bone pâté on human osteoblasts cell cultures 146
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand translocate in the Nucleus to enhance Osteoblast Specific Transcription 144
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 143
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 142
Role of Irisin on the bone-muscle functional unit 137
The effect of Irisin on bone cells in vivo and in vitro 137
Irisin Serum Levels and Skeletal Muscle Assessment in a Cohort of Charcot-Marie-Tooth Patients 136
Irisin Treatment Prevents Isoproterenol-Induced Cardiac Fibrosis in Mice 133
THE ROLE OF LIGHT ON BONE REMODELING 131
In vitro osteoclastogenesis and bone resorption during spaceflight 130
Osteotropic Cancers: From Primary Tumor to Bone 128
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 128
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 127
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 127
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 126
Antidepressant Effect of Intermittent Long‐Term Systemic Administration of Irisin in Mice 126
Irisin Modulates Inflammatory, Angiogenic, and Osteogenic Factors during Fracture Healing 124
Oxytocin is an Anabolic Bone Hormone 124
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 124
Irisin for care and prevention of osteoporosis 124
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 123
Irisin promotes growth, migration and matrix formation in human periodontal ligament cells 123
Irisin for care and prevention of osteoporosis 123
Dominant gender-non-specific direct regulation of osteoblasts and osteoclasts by the pituitary hormone oxytocin 122
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 122
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 122
A novel interplay between irisin and PTH: from basic studies to clinical evidence in hyperparathyroidism 121
Impact of 10-day bed rest on serum levels of irisin and markers of musculoskeletal metabolism 121
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 121
null 120
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 119
Oxytocin: an estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption 117
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 117
Effects of extracorporeal shock waves on murine calvaria osteoblastic cells 116
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 116
Skeleton and glucose metabolism: a bone-pancreas loop 115
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 114
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 114
Oxytocin decreases bone resorption upregulating nitric oxide synthase isoforms 113
The Role of LIGHT in Multiple Myeloma-Bone Disease 113
CELLULAR MECHANISMS OF BONE REGENERATION: ROLE OF WNT-1 IN BONE-MUSCLE INTERACTION DURING PHYSICAL ACTIVITY 112
Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption 111
Irisin prevents trabecular bone damage and tumor invasion in a mouse model of multiple myeloma 111
T cells support the osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease 110
Myokine Irisin and Its Effects Linking Bone and Muscle Function 110
Irisin Protects against Loss of Trabecular Bone Mass and Strength in Adult Ovariectomized Mice by Stimulating Osteoblast Activity 106
Lack of oxytocin retards osteoblast differentiation and bone formation 106
Increased osteoclast differentiation and bone resorption during space flight 105
Anatomy and physiology of adipose tissue 105
Irisin and Secondary Osteoporosis in Humans 104
Once-Daily Subcutaneous Irisin Administration Mitigates Depression- and Anxiety-like Behavior in Young Mice 102
Increased osteoclast activity in the presence of increased homocysteine concentrations 102
The novel role of PGC1α in bone metabolism 102
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues 100
Bone Cells 100
Elevated Expression of ADAM10 in Skeletal Muscle of Patients with Idiopathic Inflammatory Myopathies Could Be Responsible for FNDC5/Irisin Unbalance 100
Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice 99
Human osteoclasts express oxytocin receptor 99
Time-dependent unloading effects on muscle and bone and involvement of FNDC5/irisin axis 98
null 96
Irisin for care and prevention of osteoporosis 96
Irisina per la cura e la prevenzione dell'osteoporosi 95
Irisin Levels in Cerebrospinal Fluid Correlate with Biomarkers and Clinical Dementia Scores in Alzheimer Disease 95
Oxytocin Receptor Nuclear Translocation Could Be A Novel Mechanism Mediating Osteoblast Differentiation Induced By Oxytocin 94
T cell-regulation of osteoclast formation and survival involving OPG/TRAIL interaction in an vitro model from human multiple myeloma 94
The role of light (TNFSF14) on bone remodeling 94
Irisin, the novel myokine responsible for benefits of physical exercise on bone 93
Systemic Administration of Recombinant Irisin Accelerates Fracture Healing in Mice 93
In vitro bone resorption during Spaceflight 92
Anatomy and physiology of skeletal tissue: The bone cells 91
Trascriptional activation of the oxytocin promoter by estroges requires an intanct MAP kinase pathway in osteoclasts and osteoblests: a novel non classical nuclear mechanism 88
Totale 13.856
Categoria #
all - tutte 66.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022959 71 85 10 29 45 82 28 37 96 68 163 245
2022/20231.346 180 166 95 85 134 187 33 154 228 14 29 41
2023/2024645 56 96 32 57 77 145 35 18 20 34 15 60
2024/20252.705 146 28 172 88 61 295 399 219 108 196 337 656
2025/20266.421 849 327 555 588 646 364 567 276 685 542 196 826
2026/2027162 162 0 0 0 0 0 0 0 0 0 0 0
Totale 17.217